Veerja Pharmaceuticals Private Limited - Company overview

Veerja Pharmaceuticals is an active private limited company registered with ROC Delhi I on 29 May 2012, about 14 years ago.

2012-05-29 Delhi, Delhi Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹1–10 Lakh
▼ -5.6%
FY 2020
PROFIT / LOSS
Under ₹1 Lakh
▼ -34.3%
FY 2020
EBITDA
₹1–10 Lakh
▲ 63.3%
FY 2020
NET WORTH
Loss · ₹1–10 Lakh
▲ 2.5%
FY 2020
TOTAL ASSETS
₹1–10 Lakh
▼ -49.7%
FY 2020
OPEN CHARGES
-
-
PAID-UP CAPITAL
1.00 Lakh
AUTHORISED CAPITAL
2.00 Lakh
COMPANY AGE
14 Years 4 Months
since 2012-05-29
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-30
ACTIVE GST
-
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Veerja Pharmaceuticals covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Moderate
74/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (88), financial health (35), director (95) and company-foundation signals.
  • Operating for 14+ years.
Compliance Score Low risk
88/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score High risk
35/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2020.
  • Negative net worth - capital eroded by losses.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Veerja Pharmaceuticals Company identity, industry, contact, and registration details from MCA and company records.

Veerja Pharmaceuticals is an active private limited company registered with ROC Delhi I on 29 May 2012, about 14 years ago. Its registered office is at A-11, Third Floor, Pandav Nagar, Delhi.

Its filings describe the main line of business as wholesale Trading, which made up 100% of turnover.

It has three directors: Shashi Shekhar Verma, Chandra Prasad Shekhar Verma and Vivek Kumar. The longest-serving is Shashi Shekhar Verma, on the board since 2012; the most recent to join is Vivek Kumar, appointed in October 2013. Shashi Shekhar Verma is the managing director. No director has left so far.

Paid-up capital stands at ₹1 lakh out of ₹2 lakh authorised. The last AGM on record was on 30 September 2025, for accounts made up to 31 March 2025. No charges (secured loans) are registered against it.

Trading •••••••• ••••••••
  • Location A-11, Third Floor, Pandav Nagar, Delhi, Delhi - 110092
Legal NameVeerja Pharmaceuticals Private Limited
CIN / LLPINU51909DL2012PTC236626
Company No.236626
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2012-05-29
Date of AGM2025-09-30
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Delhi I
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Veerja Pharmaceuticals (3) Current board members from MCA filings, including designation and appointment details.

S
Shashi Shekhar Verma
Managing Director | Since 2012-05-29 | DIN: 03554673
C
Chandra Prasad Shekhar Verma
Whole-time director | Since 2012-05-29 | DIN: 03554686
V
Vivek Kumar
Director | Since 2013-10-05 | DIN: 06706823

Financial Performance of Veerja Pharmaceuticals Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2020
Revenue ₹1–10 Lakh ▼ -5.6%
P&L Under ₹1 Lakh ▼ -34.3%
EBITDA ₹1–10 Lakh ▲ 63.3%
Net worth Loss · ₹1–10 Lakh ▲ 2.5%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
TradeWholesale Trading100

Financial Ratios of Veerja Pharmaceuticals Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

4 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Veerja Pharmaceuticals Ownership and contribution detail from filings. Full breakdown unlocks with your report.

2 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Veerja Pharmaceuticals MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Veerja Pharmaceuticals Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veerja Pharmaceuticals Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Veerja Pharmaceuticals?
MCA does not publish an "owner" field. Veerja Pharmaceuticals is run by its directors, Shashi Shekhar Verma, Chandra Prasad Shekhar Verma and Vivek Kumar, with Shashi Shekhar Verma as managing director. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Veerja Pharmaceuticals?
Veerja Pharmaceuticals has three current directors: Shashi Shekhar Verma (since May 2012), Chandra Prasad Shekhar Verma (since May 2012) and Vivek Kumar (since October 2013). Shashi Shekhar Verma is the managing director.
What is CIN of Veerja Pharmaceuticals?
The CIN of Veerja Pharmaceuticals is U51909DL2012PTC236626. Reading it left to right: U means it is not listed, 51909 is the industry code it registered under, DL is Delhi, 2012 is the year it was registered, PTC is the company type and 236626 is its registration number.
When was Veerja Pharmaceuticals incorporated?
Veerja Pharmaceuticals was incorporated on 29 May 2012 with ROC Delhi I. That makes it about 14 years old.
What is the registered address of Veerja Pharmaceuticals?
The registered office on MCA records is A-11, Third Floor, Pandav Nagar, Delhi - 110092.
What is the current status of Veerja Pharmaceuticals?
MCA shows Veerja Pharmaceuticals as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Veerja Pharmaceuticals?
You can post to its registered office at A-11, Third Floor, Pandav Nagar, Delhi, Delhi - 110092.
What industry or business activity is Veerja Pharmaceuticals associated with?
Its MCA filings list the main business as wholesale Trading (100% of turnover).
What is paid-up capital and authorised share capital of Veerja Pharmaceuticals?
Paid-up capital is ₹1 lakh and authorised capital is ₹2 lakh, so about 50% of the authorised amount has been issued.
When did Veerja Pharmaceuticals last file accounts and hold an AGM?
The last AGM on record was on 30 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Veerja Pharmaceuticals?
MCA shows no charges registered against Veerja Pharmaceuticals, so no assets are pledged for a registered secured loan.
Have any directors left Veerja Pharmaceuticals?
No. MCA shows no former directors, so everyone appointed so far is still on the board.
What is the turnover or revenue of Veerja Pharmaceuticals?
Based on filed financial statements, the revenue of Veerja Pharmaceuticals for FY 2020 was in the ₹1–10 Lakh range. That is down 5.6% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Veerja Pharmaceuticals?
For FY 2020, the net worth of Veerja Pharmaceuticals was negative, in the ₹1–10 Lakh range.
How can I get the financial details of Veerja Pharmaceuticals?
The latest accounts on record are for FY 2020. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
Veerja Pharmaceuticals - is it listed or unlisted?
Veerja Pharmaceuticals is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Veerja Pharmaceuticals?
Veerja Pharmaceuticals is registered with ROC Delhi I.
What is the company classification of Veerja Pharmaceuticals?
MCA classifies Veerja Pharmaceuticals as: Private Limited Indian Non-Government Company.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.